Article · 23 Mar 2026
Conference abstractPublished 13 Nov 2019
Novel stability indicating LC methods for determination of tasimelteon
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tasimelteon (TAS) is a melatonin receptor agonist compound, which is currently in use for the treatment of non-24-hour sleepâÂ?Â?wake disorder in totally blind people. In this study, novel stability-indicating LC methods have been developed for the determination of TAS besides its degradation products. Three different LC set-ups were used within this study. Initially, an LC-PDA instrument was developed for quantification of TAS; the separation of TAS from its degradation products was achieved on an Ascentis® Express F5-bonded fused-core silica particle column using the mobile phase of acetonitrile: acetate buffer (0.025 M, pH 4.5): water (40:10:50, v/v/v); the elution was performed in isocratic mode at 0.8 mL minâÂ?Â?1 flow rate, detecting the analytes at 281 nm. In addition, an alternative method was developed by using an LC-DAD-MS/MS instrument; the responses of DAD and MS/ MS detectors were used as separate analytical signals for TAS and other compounds. A second-generation C18-bonded monolithic silica column was used as stationary phase in this method, while the mobile phase was a mixture of 0.1% (v/v) formic acid in water and 0.1% (v/v) formic acid in acetonitrile (60: 40 (v/v), pH=2.5). The instrumental and analytical performances of all three set-ups were compared in terms of validation parameters mentioned in ICHQ2(R1) guideline. On the other hand, a new degradation product was identified using an LC/MS-IT-TOF instrument. In conclusion, determination of TAS besides its degradation products and identification of a novel degradation product was successfully performed using the protocols reported in this study.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Research & Reviews: Journal of Pharmaceutical Analysis.
Commentary · 29 Dec 2025
Drug Quality Control Safeguarding Safety Efficacy and Compliance
Commentary · 29 Dec 2025
Spectrophotometry in Pharmaceutical and Chemical Analysis: Principles, Techniques, and Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch & Reviews: Journal of Pharmaceutical Analysis
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Serkan Levent”
- BylineArticles whose byline prints “Saniye Ozcan”
- BylineArticles whose byline prints “Aysun Geven”
- BylineArticles whose byline prints “Yusuf Ozkay”
- BylineArticles whose byline prints “Nafiz Oncu Can”